Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sci Pharmtech Inc. (4119:TWSE), powered by AI.
Sci Pharmtech Inc. is currently trading at $44.20. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sci Pharmtech Inc. on Alpha Lenz.
View Sci Pharmtech Inc.'s valuation metrics on Alpha Lenz.
“Sci Pharmtech Inc.'s ROE is 2.0%. Explore profitability and growth together.”
Ask for details →Sci Pharmtech Inc. is a prominent player in the specialty chemicals sector, primarily focusing on the development and production of Active Pharmaceutical Ingredients (APIs). It serves as a crucial link in the pharmaceutical supply chain by providing high-quality APIs that are essential for the manufacture of a wide range of prescription drugs and healthcare products. Renowned for its rigorous manufacturing standards and R&D capabilities, Sci Pharmtech is instrumental in meeting the stringent regulatory requirements of global health authorities. The company's operations significantly impact the pharmaceutical industry, particularly in areas such as generic medicine production and drug formulation. By maintaining a robust portfolio and leveraging advanced chemical synthesis techniques, Sci Pharmtech plays a vital role in ensuring the availability and affordability of medications across various therapeutic categories. It stands as a strategic partner to pharmaceutical firms worldwide, contributing to the innovation and efficiency of the global healthcare system.
“Sci Pharmtech Inc.'s ROE is 2.0%. Explore profitability and growth together.”
Ask for details →Sci Pharmtech Inc. (ticker: 4119) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
The current price is 44.2 with a P/E ratio of -x and P/B of -x.
ROE is 1.98% and operating margin is 11.55%. Annual revenue is $1.3B.